A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Pfizer
Fusion Pharmaceuticals Inc.
National Institutes of Health Clinical Center (CC)
CureOne
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)